Form D On Watch: Antriabio $53.30 million Financing. Morgan Fields Published Jul 12 D Filing

Biotechnology Antriabio, Inc. - Morgan Fields

Antriabio Financing

Antriabio, Inc., Corporation just submitted form D regarding $53.30 million equity financing. This is a new filing. Antriabio was able to fundraise $5.36 million so far. That is 10.06% of the financing offer. The total private financing amount was $53.30 million. The private financing document was filed on 2016-07-12. The reason for the financing was: Aggregate offering includes amount that may be received by Issuer upon exercise of warrants. Each whole warrant may be exercised for 1 common stock at a price of $1.65 per share for a period of 7 years from date of issuance.. The fundraising still has about $47.94 million more and is not closed yet. We have to wait more to see if the offering will be fully taken.

Antriabio is based in Colorado. The company’s business is Biotechnology. The form D was filed by Morgan Fields Chief Accounting Officer. The company was incorporated more than five years ago. The filler’s address is: 1450 Infinite Drive, Louisville, Co, Colorado, 80027. Nevan Charles Elam is the related person in the form and it has address: 1450 Infinite Drive, Louisville, Co, Colorado, 80027. Link to Antriabio Filing: 000114036116072394.

Analysis of Antriabio Offering

On average, firms in the Biotechnology sector, sell 73.77% of the total offering amount. Antriabio sold 10.06% of the offering. The financing is still open. The average fundraising size for companies in the Biotechnology industry is $3.08 million. The total amount raised is 74.11% bigger than the average for companies in the Biotechnology sector. The minimum investment for this financing was set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Antriabio Also

The Form D signed by Morgan Fields might help Antriabio, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment